This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
NMRAL1 Polyclonal Antibody
catalog :
PA5-100642
quantity :
100 uL
price :
US 464.00
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human, mouse, rat
application :
western blot
product information
Product Type :
Antibody
Product Name :
NMRAL1 Polyclonal Antibody
Catalog # :
PA5-100642
Quantity :
100 uL
Price :
US 464.00
Clonality :
Polyclonal
Purity :
Affinity chromatography
Host :
Rabbit
Reactivity :
Human, Mouse, Rat
Applications :
Western Blot: 1:500-1:2,000
Species :
Human, Mouse, Rat
Isotype :
IgG
Storage :
-20 C
Description :
The function of this protein is binding, oxidoreductase activity, and transcription repressor activity.
Immunogen :
A synthesized peptide derived from human NMRAL1(Accession Q9HBL8), corresponding to amino acid residues L159-G209.
Format :
Liquid
Applications w/Dilutions :
Western Blot: 1:500-1:2,000
Aliases :
1110025F24Rik; AI256624; HSCARG; LOW QUALITY PROTEIN: nmrA-like family domain-containing protein 1; NmrA like redox sensor 1; NMRAL1; nmral1 {ECO:0000250; NmrA-like family domain containing 1; nmrA-like family domain-containing protein 1; nmrA-like family domain-containing protein 1 {ECO:0000250; RGD1311451; SDR48A1; short chain dehydrogenase/reductase family 48A, member 1; UniProtKB:Q9HBL8}
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments